Key findings

  • 83% (45/54)of samples showed normal platelet morphology after single centrifugation at 3200 rpm for 15 minutes
  • 15% (8/54)of samples showed hemodilution, with a lower platelet concentration
  • 2% (1/54)of samples showed damaged platelets with irregular shapes and disrupted membranes
  • 85% (n=46)of smears showed a predominantly scattered platelet distribution; 15% (n=8) showed clumping

Abstract

The therapeutic application of Platelet-Rich Plasma for osteoarthritis has shown promising regenerative potential. However, there is a notable lack of information regarding the morphological characteristics of platelets within Platelet-Rich Plasma. Additionally, existing centrifugation methods rarely address their impact on platelet morphology and quality.

Objective: This study aims to describe and analyze the cytological morphology of platelets obtained through a single centrifugation protocol for Platelet-Rich Plasma preparation in patients with osteoarthritis.

Methods: A prospective observational study was conducted using 54 blood samples obtained from osteoarthritis patients (Kellgren & Lawrence Grades I-III). Blood samples were centrifuged at 3200 rpm for 15 minutes. Platelet-Rich Plasma blood smears were prepared, stained using Hemacolor, and evaluated under optical microscope by a professional histopathologist. Platelet morphology was assessed for size, granularity, membrane integrity, and aggregation. The platelet distribution patterns (scattered or clumped), and morphology (normal, diluted, or damaged) were documented.

Results: Out of the 54 samples analyzed, 83% (45/54) exhibited normal platelet morphology characterized by uniform size, intact membranes, and appropriate granularity, as illustrated in Figure 1. Hemodilution was identified in 15% (8/54) of the samples, leading to lower platelet concentrations, while 2% (1/54) presented damaged platelets with irregular shapes and disrupted membranes. Platelet distribution was predominantly scattered (85%), which is indicative of effective separation during centrifugation, while 15% of the samples showed clumping, potentially reflecting premature activation during processing.

Conclusion: The single centrifugation protocol at 3200 rpm effectively preserved platelet morphology in 83% of the samples, supporting its utility for Platelet-Rich Plasma preparation. This study highlights the critical role of preserving platelet morphology in Platelet-Rich Plasma quality and suggests that further research should be conducted to explore the relationship between platelet integrity and the release of growth factors. Developing standardized methodologies to assess and preserve platelet morphology will be vital to improving Platelet-Rich Plasma preparation and ensuring its regenerative potential. The presence of hemodilution and damaged platelets in a subset of samples reveals areas for optimization in centrifugation protocols.

Introduction

Osteoarthritis is a chronic degenerative joint disease that, according to the most recent estimates from the Global Burden of Disease Study, affected approximately 595 million people globally in 2020 (7.6% of the global population), a figure that represents a 132.2% increase in the total number of cases since 1990 and whose projection continues to rise towards 2050.1 This disease also has a major economic impact in developing countries. In Guatemala, this disease is prevalent, affecting the working-age population; access to medical care is limited, and low economic income often prevents surgical interventions such as arthroplasty. The universities that train medical professionals in the country form part of the health structure that cares for the population, including traumatology and orthopedics patients belonging to the public sector. Therefore, approximately 13 years ago, it was decided to initiate research on the application of Platelet-Rich Plasma (PRP) as an orthobiological treatment by developing a standardized preparation protocol; since then, around 2,400 joint infiltrations have been performed, achieving excellent clinical results. Medical students rotate for a 4-month period in a social aid clinic where PRP infiltrations are carried out; during this period, they participate in the preparation and application of this treatment.

Current evidence on PRP indicates that its efficacy, based on its composition, is influenced by the preparation method, which means that two PRP preparations may not be equivalent.

Evaluating platelet morphology is essential, as structural alterations and premature degranulation, often induced by mechanical stress during centrifugation, compromise cellular viability.2 This cellular viability complexity has been extensively reviewed by Andia and Maffulli 3, who described PRP as a source of hundreds of bioactive molecules capable of modulating angiogenesis, inflammation, and cartilage anabolism in osteoarthritic joints. Detecting these morphological changes via optical microscopy in processed platelets,compared to resting, unprocessed circulating platelets, is essential for predicting whether the final product will retain its capacity for controlled growth factor release following activation with calcium gluconate. 4

To understand and reproduce the clinical effects of PRP, it is necessary to properly characterize the obtained product. According to the literature, platelet quality is primarily evaluated using expensive and poorly accessible methods (flow cytometry, electron microscopy, artificial intelligence), whereas evaluation with optical microscopy is low-cost, accessible, and potentially applicable at the point of care. Although optical microscopy is not equivalent to flow cytometry or electron microscopy, it can provide complementary information in a resource-limited context, such as in developing countries or rural areas.

Due to the favorable clinical evolution of patients who received PRP prepared with the developed "in-house" protocol, a decision was made to evaluate the platelet morphology of the PRP samples under optical microscopy in terms of size, granularity, membrane integrity, and platelet aggregation. Consequently, the objective of this study was to describe and analyze the cytological morphology of platelets obtained through a single centrifugation protocol for PRP preparation in patients with osteoarthritis, using optical microscopy as an accessible quality control tool in a resource-limited setting , which refers to clinical and research environments constrained by limited institutional infrastructure, where advanced diagnostic technologies, such as flow cytometry or electron microscopy, are unavailable or cost-prohibitive. In these operational contexts, optical microscopy combined with rapid staining techniques provides an accessible, low-cost, and reliable alternative for real-time cellular evaluation.

Public healthcare settings in Guatemala lack high-cost technological infrastructure, such as flow cytometry or proprietary commercial PRP kits; consequently, they rely on accessible, low-cost manual methods for point-of-care processing and quality control. 4,5

Methods

A prospective and observational study was conducted during the 2024-2025 academic clinical rotation, at the Clínica San Antonio (Centro Universitario de Occidente) and the Amir Wellness Center in Quetzaltenango, Guatemala. The research took place over a 4-month period, with the objective of evaluating the morphology of platelet-rich plasma (PRP) obtained through an "in-house" centrifugation protocol.

The study included 54 blood samples mainly from patients diagnosed with osteoarthritis, of Mayan ethnic origin, predominantly female (68.5%) with a mean age of 59.6 years, and rural residents.

The PRP preparation protocol was developed under strict ethical guidelines, with informed consent obtained from all participants prior to blood extraction.

Venipuncture was performed ensuring rigorous asepsis and antisepsis measures including sterile attire. A total of 32 ml of peripheral venous blood was extracted per patient. The sample was distributed into eight 4-ml glass tubes, which had their outer surfaces previously disinfected with an iodine solution. To preserve cellular integrity, each tube contained 0.5 ml of 3.8% sodium citrate as an anticoagulant.

To obtain the PRP, a single centrifugation protocol was utilized. The tubes were centrifuged at 3200 revolutions per minute (rpm) for 15 continuous minutes with a G-force of 1431 × g (the rotational speed, measured in revolutions per minute or RPM, and the rotor radius, the distance from the center of the axis to the bottom of the tube). RCF = 1.118 × 10^-5 × r × (RPM)^2.

This standard parameter was used to isolate the plasma fraction and concentrate the platelets above baseline values, adapting to the available infrastructure of the clinic.

The processing of the centrifuged samples was carried out inside a sterile hood to prevent any contamination. For the cell activation phase, a pre-filled syringe with 1.5 ml of 10% calcium gluconate was used. Through careful aspiration with this syringe, 1.1 cc of the platelet-rich fraction was extracted from each of the 8 tubes. This procedure yielded an approximate final volume of 9 to 10 ml of activated PRP per patient, ready for analysis and subsequent clinical use.

Cytological preparation and Hemacolor staining

Immediately after obtaining the activated PRP, peripheral blood smears were prepared from each of the 54 samples and allowed to air-dry at room temperature. For morphological evaluation, the Hemacolor rapid staining technique was used.

The standardized staining protocol consisted of the following sequential steps: Initial fixation by immersion in methanol, followed by immersion in Reagent #1 (a red staining solution containing eosin) and subsequent immersion in Reagent #2 (a blue staining solution containing hematoxylin). The slides were then gently rinsed with running water to remove excess stain. Once the stained smears were completely dry, they were permanently mounted with a coverslip using Entellan mounting medium to ensure optimal preservation and clarity for cytological analysis.

Microscopic examination and morphological criteria

Microscopic evaluation was performed by a professional histopathologist using a high-resolution light microscope. An initial rapid assessment of each smear was performed using a 10× objective to evaluate overall slide quality and cellular distribution. A detailed evaluation was subsequently performed using a 100× oil-immersion objective. A systematic continuous scanning technique was applied across the slides to examine as many microscopic fields as possible and ensure a representative assessment of the sample.

Cytological analysis thoroughly evaluated the post-centrifugation structural integrity of the platelets based on the following morphological criteria:

  • Size and shape: Preservation of a regular, well-defined, round or oval morphology, together with an appropriate platelet size.
  • Staining and granularity: Presence of the characteristic pale blue cytoplasm accompanied by slight, fine granularity, indicative of preserved intracellular structures.
  • Distribution and aggregation: Assessment of spatial distribution patterns, specifically documenting whether platelets were uniformly dispersed or showed a tendency toward clustering and platelet aggregate formation.

The cytological analysis focused on evaluating post-centrifugation size, granularity, membrane integrity, and platelet aggregation. Platelet distribution patterns were also documented, classifying them as scattered or clumped. Ultimately, based on these standardized criteria, platelet membrane integrity and overall morphology were definitively categorized into one of three states: normal, swollen (edematous), or fragmented.

Results

A total of 54 platelet-rich plasma (PRP) samples were evaluated. Microscopic morphological analysis revealed that 83% (n=45) of the samples presented an adequately preserved cellular architecture, with normal platelet morphology characterized by uniform size, intact membranes, and adequate granularity (Figure 1).

Figure 1. Photograph obtained by optical microscopy.

Regarding morphological alterations, hemodilution (edematous cells) and a consequent reduction in platelet concentration was observed in 15% (n=8) of the cases. Only 2% (n=1) of the samples exhibited cellular damage, characterized by irregular shapes and altered membranes.

Regarding post-centrifugation platelet distribution patterns, 85% (n=46) of the smears showed a predominantly scattered distribution, which is indicative of effective separation during centrifugation, while clumping was observed in 15% (n=8) of the samples, which could reflect premature activation during processing.

Table 3. Results of the platelet morphological analysis.

Parameter EvaluatedCategory / FindingPercentage (%)Number of Samples (n=54)
Platelet MorphologyNormal (Preserved architecture)83%45
Platelet MorphologyDiluted (Hemodilution/Edema)15%8
Platelet MorphologyFragmented / Damaged2%1
Distribution PatternScattered85%46
Distribution PatternClumped (Clumping)15%8

Discussion

The main evidence in this study is that the "in-house" single centrifugation protocol preserves adequate platelet architecture in 83% of the samples (45/54), with frank structural damage in only 2% of the cases. This figure is the core of the discussion: beyond any isolated variable of the protocol (g-force, tube type, volume, or activation), what the study demonstrates is that, as a whole, these methodological decisions were compatible with obtaining a morphologically intact PRP, an indispensable prerequisite for the product to have therapeutic value.

1. Morphology as a quality indicator, beyond platelet count

Recent literature has begun to question the idea that the efficacy of PRP depends solely on the absolute platelet count. Costa et al. (2026)6 argue that platelet count is a convenient variable to measure but is biologically insufficient, as a platelet that is numerically present but has premature degranulation or membrane damage provides little regenerative value; they propose evaluating structural and functional integrity (viability, membrane integrity, granule content) as a more faithful marker of the preparation's therapeutic potency.

Our study did not quantify the absolute number of platelets, but it did precisely evaluate that qualitative dimension—uniform size, intact membrane, preserved granularity—that this movement identifies as the most relevant. For this reason, 83% of normal morphology should be interpreted not as an accessory data point, but as direct evidence that the protocol delivers a functionally competent product, even without the infrastructure to quantify growth factors. This reasoning parallels classification frameworks such as the PAW system proposed by DeLong et al.7, which explicitly incorporates platelet count, activation method, and white blood cell content as independent axes of PRP quality, rather than relying on platelet concentration alone.

2. Potential platelets changes can affect the method's effectiveness

Physiologically, inactive and functional platelets maintain a discoid morphology. When subjected to thermal, mechanical, or chemical stress during the preparation protocol, they undergo a shape change, transforming into spherical structures with the extension of pseudopodia.8 This premature morphological change alters their membrane receptors and shortens their metabolic survival within the microenvironment of the lesion.2

Consequently, this structural damage triggers a premature and uncoordinated release of cytokines and growth factors before they reach the target tissue.4,5 This fundamental understanding of platelet physiology clarifies why preserving platelet morphology is essential for the clinical effectiveness and biological functionality of PRP: a structurally compromised platelet concentrate loses its orthobiologic potential, resulting in a diminished immunomodulatory and tissue-repair capacity when treating osteoarthritis.4

3. Centrifugal force, revolutions, and centrifugation time

The protocol used 3200 rpm for 15 continuous minutes (1431 × g) in a single centrifugation Notably, these parameters are identical to those described by Kon et al.9, who employed the GPS III system, used in one of the most widely cited PRP studies for cartilage pathology and osteoarthritis, in a single centrifugation cycle at 3200 rpm for 15 minutes. Milants et al.10, in their technical analysis of clinical trials with good results in knee osteoarthritis, found that the single centrifugation technique predominated in the studies classified as "very good responders" (5 out of 7 trials), and concluded that, given the lack of standardization in the sector, single centrifugation and a moderate platelet concentration (less than 5 times the baseline value) were the variables most consistently associated with good clinical outcomes. Filardo et al.12 directly compared single centrifugation PRP against double centrifugation in 144 patients with cartilage degeneration and found no significant differences in clinical improvement between both methods at 12 months, which supports the idea that single centrifugation—simpler and less costly—is clinically equivalent to more complex protocols. This is relevant in justifying the methodological choice of our study in a resource-limited environment.

At the same time, it is worth recognizing that Costa et al.6 point out that protocols with high centrifugal force and prolonged times can induce mechanical stress, premature degranulation, and membrane rupture, so a higher numerical platelet yield does not equate to higher quality if they arrive "empty". Our value of 1431 g for 15 minutes lies within a medium-high range compared to what is reported in the literature; the fact that only 2% of the samples showed frank fragmentation suggests that, in this case, the balance between separation efficiency and structural preservation was favorable.

4. Tube type: open technique with glass tubes

The recommendations of the IADVL working group13 on PRP preparation distinguish two main approaches: the closed technique, which uses commercial kits with gel separation tubes, and the open technique, which uses simple tubes (usually glass) without a separator gel, with manual aspiration of the buffy coat under a sterile hood. Our protocol clearly corresponds to this second category: 4 ml glass tubes with 3.8% sodium citrate as the sole additive, without separator gel, processed in a sterile hood. The open technique is recognized as a low-cost and reasonably effective option, particularly suitable for scenarios such as a social aid clinic without access to commercial kits. Its main limitation compared to gel tubes is its higher dependency on the operator's skill during the aspiration of the platelet-rich fraction, which could partially explain the variability observed between the normal morphology group and the hemodilution group (15%, n=8).

5. Volume of extracted blood and final volume of Platelet-Rich Plasma

A total of 32 ml of peripheral blood was extracted per patient, distributed in eight 4-ml tubes, yielding a final volume of 9 to 10 ml of activated PRP. Bansal et al.14 standardized a method featuring an absolute count of 10 billion platelets in 8 ml of PRP, discovering that absolute count—not just relative concentration—was the critical factor in sustaining the chondroprotective effect at a one-year follow-up; their final volume (8 ml) is very close to ours (9-10 ml). Milants et al.10 report that, in the trials with the best clinical responses, the injected volume varied between 2.5 and 8 ml, placing our final volume at the upper end of that range.

It is important to balance this discussion with a relevant counterpoint: the RESTORE trial (Bennell et al., JAMA 2021)15, a rigorously controlled randomized clinical trial, found no significant differences between intra-articular PRP and placebo in regard to pain or the volume of PRP infiltrated into the medial tibial cartilage at 12 months for knee osteoarthritis. This negative outcome, deriving from a methodologically sound design, serves as a useful reminder that an adequate extraction volume and technique alone do not guarantee clinical efficacy and indirectly reinforces the argument that the biological quality of the preparation (morphology, functional integrity) may be more decisive than the administered volume or dose.

An additional piece of relevant data for this section comes from Turajane et al.16, who studied PRP composition in 335 patients with knee osteoarthritis; they found that baseline whole blood platelet concentration inversely correlates with the concentration factor achieved in PRP patients with lower baseline counts achieved an average increase of 6.9 times, versus only 4.2 times in those starting with a higher baseline count.

This suggests that the final concentration tends to stabilize within a somewhat narrow range regardless of the starting point, a phenomenon the authors connect with the work of Weibrich et al. (2004), who described that excessively high platelet concentrations can inhibit osteoblastic activity rather than enhance it. This finding aligns with the argument that a protocol's objective should not be to indefinitely maximize platelet concentration, but to reach a suitable therapeutic range while preserving the structural integrity of the harvested platelets.

6. Platelet activation with calcium gluconate

The protocol activated the platelet-rich fraction with 10% calcium gluconate immediately prior to final aspiration. Margono et al.17 specifically studied the effect of calcium gluconate as a coadjuvant to activation with calcium chloride, confirming that both agents trigger the early release of platelet-derived growth factors through the formation of a fibrin clot within the first 15 minutes after activation. This places our protocol within the standard exogenous activation practices outlined in the literature.

It is worth discussing an important methodological nuance here: the peripheral smear for morphological evaluation was conducted immediately after the activated PRP was obtained. This means that the 15% of samples exhibiting observed platelet aggregation, or clumping, could reflect, at least in part, the expected physiological activation process (platelet aggregation induced by calcium gluconate) rather than strictly an unwanted premature activation during prior processing. Differentiating between "aggregation due to intentional activation" and "premature activation due to centrifugation stress" is non-trivial with basic optical microscopy, a point worth highlighting as an interpretative limitation rather than an adverse finding.

7. Preparation method: contributions from the comparison of anticoagulants

Carvalho et al.18 compared sodium citrate against EDTA as anticoagulants in PRP preparation, observing a significantly higher platelet recovery and increased platelet activity (P-selectin, PAC-1) in the EDTA group. Our protocol utilized 3.8% sodium citrate, the most widely reported anticoagulant in the PRP literature for intra-articular use and generally considered the de facto standard due to its safety profile; Carvalho et al.18's finding does not invalidate this choice, but it does raise a logical question for future iterations of the protocol regarding whether the choice of anticoagulant could be further optimized without compromising product safety.

8. Quality over quantity: the guiding thread of the discussion

Costa et al.’s article6 synthesizes the argument that unifies all the preceding points: the efficacy of PRP relies more on the biological competence of the delivered platelets—membrane integrity, intact alpha granule content, and a coordinated capacity for releasing growth factors—than on the raw number of platelets per microliter. The findings from Turajane et al.16 (concentration tends to stabilize independently of baseline count) and Bosetti et al.11 (a higher fibrin density did not improve cellular colonization of the clot) exemplify this same principle: in both scenarios, "more platelets" did not linearly translate to a "better product". Viewed through this framework, each methodological decision in our protocol (single centrifugation at 1431 × g/15 min, glass tubes without separator gel, a 32 ml blood volume yielding 9-10 ml of PRP, activation via calcium gluconate) must be assessed not just by its ability to concentrate platelets, but by its capacity to structurally preserve them. The 83% preserved morphology and 85% scattered distribution lacking spontaneous aggregation suggest that, collectively, the protocol reasonably achieves this objective, even when operating with limited resources and without specialized cytometry equipment or viability assays.

This perspective aligns with the most recent synthesis of the field by Andia et al.19, who framed PRP research as an interconnected “ecosystem” spanning mechanistic biology, product characterization, and precision medicine, explicitly concluding that leukocyte and platelet concentrations alone do not explain clinical outcomes—underscoring the importance of structural and patient-specific factors, consistent with the morphological focus of the present study.

9. Platelet quality according to donor age and gender

The demographic profile of the sample, overwhelmingly female (68.5%) and greater than half the patients over 60 (51.9%), introduces a further relevant consideration for interpreting the morphological findings. General hematological literature suggests that platelet counts progressively decrease with age: in a recent cohort of 384 patients, Sánchez-Pérez et al.20 identified a statistically significant negative correlation between age and platelet count (r = -0.175; p < 0.01), with a more pronounced decline starting around 40-60 years, although females demonstrated a slightly higher count than males, although not reaching statistical significance within their cohort.

Beyond mere counts, evidence exists that age and gender specifically impact the quality of the obtained PRP, and not solely in whole blood. Trevissón et al.21 compared the cellular composition of PRP between men and women, additionally stratifying by age and menopause status (≤50 years versus >50 years). They discovered significant differences in leukocyte composition, notably within the phagocytic cell population and lymphocyte count, associated with the female gender post-50 years. Given that 37 out of 54 patients in our sample were women and a substantial portion over 50-60 years, it is plausible that some of the observed morphological variability (e.g., the 15% of samples displaying hemodilution) was influenced, at least partially, by physiological differences related to the age and hormonal status, rather than exclusively by technical variables within the centrifugation protocol.

Ultimately, donor age affects not only the quantity and cellular makeup of the PRP but also its functional regenerative capacity. In a study directly comparing PRP from young donors (18-35 years) against older donors (≥65 years) in an osteoarthritis model, Chowdhary et al.22 established that PRP from young donors induced a more favorable chondrocytic phenotype (increased expression of type II collagen and SOX-9) and improved cartilage integrity in vivo, whereas PRP from older donors yielded no significant improvement in either parameter.

Considering our population's average age was 59.6 years, with more than half of the patients in their sixth to eighth decade of life, this finding holds particular relevance: this centrifugation protocol adequately preserves platelet morphology, as evidenced by our 83% normal samples.

Limitations

  • The morphological evaluation was qualitative and conducted by a single observer (a histopathologist), lacking a second blind reading which would have enabled the calculation of interobserver agreement.
  • Absolute platelet counts were not quantified, nor were functional biomarkers (growth factors, viability, P-selectin) measured, rendering the documented "good morphology" an indirect indicator—albeit one supported by the literature—of functional quality rather than a direct measurement of bioactivity.
  • The study did not include a comparison group processed using an alternative protocol (e.g., double centrifugation, commercial kits with separator gels, or alternative anticoagulants), limiting the ability to attribute the positive morphological outcomes to any specific protocol variable rather than the combined approach.

Conclusion

This study demonstrates that the single centrifugation protocol at 3200 rpm for 15 minutes preserved an adequate platelet architecture in 83% of the samples, with frank structural damage occurring in only 2% of cases. The predominantly scattered distribution (85%) of post-centrifugation platelets indicated an effective separation of cellular components. These results suggest that the single centrifugation protocol, when adapted to a resource-limited setting with simple glass tubes and devoid of specialized commercial equipment, successfully obtains a morphologically intact PRP serving as a foundational material for potential clinical applications.

The preservation of platelet morphology documented in this study is a fundamental prerequisite for obtaining a biologically competent product. Although this work centered on morphological characterization and did not directly assess functional bioactivity or clinical outcomes, the findings support the protocol's viability for incorporation into intra-articular infiltration procedures. It should be noted that the sample studied was predominantly female (68.5%).

To the best of our knowledge, this work represents a novel contribution given the limited indexed literature regarding the morphological characterization of PRP. In contrast to the predominant focus on quantitative platelet concentration, our findings highlight the critical relevance of qualitative platelet integrity and structural preservation as key determinants of PRP quality.

Declarations

Conflict of Interest Statement
The authors declare no conflicts of interest.
Funding Statement
None.
Acknowledgements
None.

References

  1. GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatology. September 2023. Accessed August 29, 2026. https://pubmed.ncbi.nlm.nih.gov/37675071/.
  2. Dang E, Chen Y, Wang W, et al. A comparative study of platelet storage lesion in platelet-rich plasma under cryopreservation. Ann Hematol. 2024;103(2):631-643. doi:10.1007/s00277-023-05580-0
  3. Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nature Reviews Rheumatology. October 2013. Accessed August 29, 2026. https://doi.org/10.1038/nrrheum.2013.141.
  4. Mercader-Ruiz J, Beitia M, Delgado D, et al. Current challenges in the development of platelet-rich plasma-based therapies. Biomed Res Int. 2024;2024:6444120. doi:10.1155/2024/6444120
  5. Tey RV, Haldankar P, Joshi VR, Raj R, Maradi R. Variability in platelet-rich plasma preparations used in regenerative medicine: a comparative analysis. Stem Cells Int. 2022; 2022:3852898. doi:10.1155/2022/3852898
  6. Costa FR, Purita J, Martins R, et al. Beyond platelet count: Rethinking platelet-rich plasma efficacy through growth factor biology and functional quality. MDPI. January 23, 2026. Accessed August 29, 2026. https://www.mdpi.com/2075-1729/16/2/188
  7. DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. July 2012. Accessed August 29, 2026. https://pubmed.ncbi.nlm.nih.gov/22738751/.
  8. Heijnen HFG, Korporaal SJA. Platelet morphology and ultrastructure. RESEARCH GATE . March 2017. Accessed October 3, 2026. https://www.researchgate.net/publication/396539243_Platelet_Morphology_and_Ultrastructure
  9. Kon E, Mandelbaum B, Buda R, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. November 2011. Accessed August 29, 2026. https://pubmed.ncbi.nlm.nih.gov/21831567/.
  10. Milants C, Bruyère O, Kaux J-F. Responders to platelet-rich plasma in osteoarthritis: A technical analysis. BioMed Research International. 2017. Accessed August 29, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC5585615/.
  11. Bosetti M, Boffano P, Marchetti A, Leigheb M, Colli M, Brucoli M. The number of platelets in patient's blood influences the mechanical and morphological properties of PRP-clot and lysophosphatidic acid quantity in PRP. International Journal of Molecular Sciences. December 24, 2019. Accessed August 29, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC6982162/.
  12. Filardo G, Kon E, Pereira Ruiz MT, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surgery, Sports Traumatology, Arthroscopy. October 2012. Accessed August 29, 2026. https://pubmed.ncbi.nlm.nih.gov/22203046/.
  13. Dashore S, Chouhan K, Nanda S, Sharma A. Preparation of platelet-rich plasma: NATIONAL IADVL PRP taskforce recommendations. Indian Dermatology Online Journal. November 25, 2021. Accessed August 29, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC8664176/.
  14. Bansal H, Leon J, Pont JL, et al. Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy. Scientific Reports. February 17, 2021. Accessed August 29, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC7889864/
  15. Bennell K, et al. Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA. November 2021. Accessed August 29, 2026. https://pubmed.ncbi.nlm.nih.gov/34812863/.
  16. Turajane T, Cheeva-Akrapan V, Saengsirinavin P, Lappaiwong W. Composition of platelet-rich plasma prepared from knee osteoarthritic patients: Platelets, leukocytes, and subtypes of leukocyte. Cureus. March 20, 2023. Accessed August 29, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC10114603/
  17. Margono A, et al. The Effect of Calcium Gluconate on Platelet Rich Plasma Activation for VEGF-A Expression of Human Dental Pulp Stem Cells. European Journal of Dentistry. May 2022. Accessed August 29, 2026. https://pubmed.ncbi.nlm.nih.gov/34937106/.
  18. Carvalho A, Ferreira AF, Soares M, et al. Optimization of platelet-rich plasma preparation for regenerative medicine: Comparison of different anticoagulants and resuspension media. Bioengineering (Basel, Switzerland). February 23, 2024. Accessed August 29, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC10967741/
  19. Andia I, Silvestre A, Del Amo C, Eymard F, Bard H. The Platelet-Rich Plasma research ecosystem: From mechanistic insights to precision treatment in knee osteoarthritis. Regenerative Therapy. November 2025. Accessed August 29, 2026. https://pubmed.ncbi.nlm.nih.gov/41282491/.
  20. Sánchez-Pérez A, Palma-Sánchez A, Jornet-García A, Moya-Villaescusa MJ, Montoya-Carralero JM. Influence of age and sex on platelet count: Implications for optimizing growth factor-rich plasma preparation. Journal of Clinical and Experimental Dentistry. October 17, 2025. Accessed August 29, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12742649/
  21. Trevissón B, Becerro-de-Bengoa-Vallejo R, Sevillano D, González N, Losa-Iglesias ME, López-López D, Alou L. Influence of Sexual Dimorphism, Aging, and Differential Cell Capture Efficiency of Blood Separation Systems on the Quality of Platelet-Rich Plasma. Journal of Clinical Medicine. March 18, 2022. Accessed August 29, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC8953315/
  22. Chowdhary K, Sahu A, Iijima H, Shinde S, Borg-Stein J, Ambrosio F. Aging Affects the Efficacy of Platelet-Rich Plasma Treatment for Osteoarthritis. American Journal of Physical Medicine & Rehabilitation. December 7, 2022. Accessed August 29, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC10245083/.
  23. Prodromidis AD, Charalambous CP, Moran E, Venkatesh R, Pandit H. The role of Platelet-Rich Plasma (PRP) intraarticular injections in restoring articular cartilage of osteoarthritic knees. A systematic review and meta-analysis. Osteoarthritis and Cartilage Open. November 2022. Accessed August 29, 2026. https://pubmed.ncbi.nlm.nih.gov/36474791/
  24. Belk JW, Kraeutler MJ, Houck DA, Goodrich JA, Dragoo JL, McCarty EC. Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. American Journal of Sports Medicine. January 2021. Accessed August 29, 2026. https://pubmed.ncbi.nlm.nih.gov/32302218/
  25. Belk JW, et al. Platelet-rich plasma outcomes in knee osteoarthritis are associated with the amount of total deliverable platelets: A systematic review and meta-analysis. PM&R. 2025. Accessed August 29, 2026. https://pubmed.ncbi.nlm.nih.gov/40980837/

Article information

Authors

  • A. Cifuentes SosaAmir Wellness Center - Iniciativa Guatemalteca de Ortobiológicos y Rehabilitación, Quetzaltenango, Guatemala.
  • P. De León FajardoDepartment of Clinical Laboratories and Pathology at Roosevelt Hospital, Guatemala, Guatemala.
  • N. González Licardie de AnchetaFamily Medicine Program Clínica San Antonio at Centro Universitario de Occidente, Universidad de San Carlos de Guatemala, Quetzaltenango, Guatemala.
  • F. Rodas FloresFamily Medicine Program Clínica San Antonio at Centro Universitario de Occidente, Universidad de San Carlos de Guatemala, Quetzaltenango, Guatemala.
  • C. Brincker NicolasFamily Medicine Program Clínica San Antonio at Centro Universitario de Occidente, Universidad de San Carlos de Guatemala, Quetzaltenango, Guatemala.
  • R. López MéndezFamily Medicine Program Clínica San Antonio at Centro Universitario de Occidente, Universidad de San Carlos de Guatemala, Quetzaltenango, Guatemala.

How to cite

Cifuentes Sosa, A., De León Fajardo, P., et al., 2026. Cytological analysis of platelet morphology obtained through platelet-rich plasma for the treatment of osteoarthritis. Medical Research Archives, [online] 14(10). https://doi.org/10.18103/mra.v14i10.7890

Record

Journal
Medical Research Archives
Section
Research Articles
Published
31 October 2026
ISSN
2375-1924
Downloads
86

Copyright and licence

Published by the European Society of Medicine under a Creative Commons Attribution 4.0 International licence (CC BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original authors and source are credited.